First Trust Nasdaq Pharmaceuticals ETF (FTXH)
- Expense ratio0.57%
- Net assets$1.11B
- Dividend yield0.71%
- 1-year return+47.07%
- Holdings50
FTXH ETF price chart
FTXH quote & trading statistics
FTXH performance
Total return · as of October 17, 2026- YTD+26.79%
- 1 year+47.07%
- 3 years+18.49%/yr
- 5 years+11.86%/yr
- 10 years+9.23%/yr
- 1Y volatility
- 13.62%
- 3Y volatility
- 14.05%
- 3Y Sharpe ratio
- 0.96
Returns include reinvested distributions; 3-, 5- and 10-year figures are annualized.
FTXH top 10 holdings
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 7.97% |
| 2 | ABBV | AbbVie Inc | 7.92% |
| 3 | PFE | Pfizer Inc | 7.47% |
| 4 | MRK | Merck & Company Inc | 6.85% |
| 5 | JNJ | Johnson & Johnson | 6.57% |
| 6 | VTRS | Viatris Inc | 3.89% |
| 7 | BIIB | Biogen Inc | 3.86% |
| 8 | GILD | Gilead Sciences Inc | 3.76% |
| 9 | ZTS | Zoetis Inc | 3.73% |
| 10 | AMGN | Amgen Inc | 3.48% |
The top 10 holdings make up 55.5% of the fund (50 holdings in total). As of October 17, 2026.
About First Trust Nasdaq Pharmaceuticals ETF
The fund will normally invest at least 80% of its net assets (including investment borrowings) in the securities that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking. It is non-diversified.
FTXH ETF FAQ
What is the FTXH expense ratio?
First Trust Nasdaq Pharmaceuticals ETF has a net expense ratio of 0.57%, or $57.00 a year for every $10,000 invested.
How much money is in FTXH?
First Trust Nasdaq Pharmaceuticals ETF has about $1.11B in net assets.
What are the top holdings of FTXH?
The largest positions in FTXH are Eli Lilly and Company (7.97%), AbbVie Inc (7.92%), Pfizer Inc (7.47%). The fund holds 50 securities in total.
How has FTXH performed?
FTXH returned +47.07% over the past year and +11.86% a year over the past five years, including reinvested distributions.
Does FTXH pay dividends?
FTXH has a dividend yield of 0.71% and pays distributions na.
When was FTXH launched?
First Trust Nasdaq Pharmaceuticals ETF began trading on September 20, 2016.
ETFs similar to FTXH
Funds that track the same index or whose top-10 holdings overlap most with FTXH's. Overlap: shared top-10 weight as a share of the larger top-10 total of the two funds.
| Symbol | Fund | Overlap | Expense ratio | Net assets | 1-year return |
|---|---|---|---|---|---|
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | — | 0.57% | $1.11B | +47.07% |
| PJP | Invesco Dynamic Pharmaceuticals ETF | 70% | 0.57% | $552.4M | +35.12% |
| PBPH | Portfolio Building Block World Pharma and… | 64% | — | $1.09B | — |
| IYH | iShares U.S. Healthcare ETF | 63% | 0.39% | $4.34B | +25.12% |
| FHLC | Fidelity MSCI Health Care ETF | 62% | 0.07% | $3.54B | +25.78% |
| TRUH | VanEck Healthcare TruSector ETF | 62% | — | $615,962 | — |
| XLV | Health Care Select Sector SPDR Fund | 61% | 0.09% | $44.31B | +26.02% |
| VHT | Vanguard Health Care ETF | 61% | 0.10% | $19.67B | +23.71% |